Nthabi in Lesotho - Implementation
NCT04354168 is an interventional trial sponsored by Boston University. As of 18 Nov 2026, it is completed. It studies Preconception Care. The registry lists an enrollment of 160 participants at 1 site in 1 country. The registry lists a start date of 8 Nov 2021 and a primary completion date of 25 Aug 2022.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT04354168 |
| Status | Completed |
| Study type | Interventional trial |
| Lead sponsor | Boston University |
| Enrollment | 160 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Preconception Care |
| Start | 8 Nov 2021 |
| Primary completion | 25 Aug 2022 |
| Study completion | 25 Aug 2022 |
| Last update posted | 18 Sept 2023 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Brian Jack, MD
Boston University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Lesotho Boston Health Alliance
Maseru
Sites by country
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT04354168
Each answer restates registry values shown on this page.
What is NCT04354168?
NCT04354168 is an interventional trial sponsored by Boston University. It studies Preconception Care.
Who leads NCT04354168?
The registry names Brian Jack, MD (principal investigator, Boston University) as the overall official.
Where does NCT04354168 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: Lesotho.
When did NCT04354168 end?
The registry lists a primary completion date of 25 Aug 2022 and a study completion date of 25 Aug 2022. The sponsor last updated the record on 18 Sept 2023.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.